Korkmaz OT - Search Results

1

7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis.

Korkmaz OT, Aytan N, Carreras I, Choi JK, Kowall NW, Jenkins BG, Dedeoglu A. Korkmaz OT, et al. Neurosci Lett. 2014 Apr 30;566:286-91. doi: 10.1016/j.neulet.2014.02.058. Epub 2014 Mar 15. Neurosci Lett. 2014. PMID: 24637017 Free PMC article.

2

Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.

Korkmaz O, Ay H, Ulupinar E, Tunçel N. Korkmaz O, et al. J Mol Neurosci. 2012 Nov;48(3):565-73. doi: 10.1007/s12031-012-9781-x. Epub 2012 Apr 29. J Mol Neurosci. 2012. PMID: 22544516

3

Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.

Korkmaz OT, Ay H, Aytan N, Carreras I, Kowall NW, Dedeoglu A, Tuncel N. Korkmaz OT, et al. J Mol Neurosci. 2019 Jul;68(3):389-396. doi: 10.1007/s12031-018-1226-8. Epub 2018 Nov 29. J Mol Neurosci. 2019. PMID: 30498985

4

Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP.

Korkmaz OT, Arkan S, Öncü-Kaya EM, Ateş N, Tunçel N. Korkmaz OT, et al. Neurosci Lett. 2021 Nov 20;765:136268. doi: 10.1016/j.neulet.2021.136268. Epub 2021 Sep 24. Neurosci Lett. 2021. PMID: 34571088

5

Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Korkmaz OT, Tunçel N, Tunçel M, Oncü EM, Sahintürk V, Celik M. Korkmaz OT, et al. J Mol Neurosci. 2010 Jun;41(2):278-87. doi: 10.1007/s12031-009-9307-3. Epub 2009 Dec 2. J Mol Neurosci. 2010. PMID: 19953344

6

Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.

Tunçel N, Korkmaz OT, Tekin N, Şener E, Akyüz F, Inal M. Tunçel N, et al. Among authors: korkmaz ot. J Mol Neurosci. 2012 Jan;46(1):51-7. doi: 10.1007/s12031-011-9618-z. Epub 2011 Aug 18. J Mol Neurosci. 2012. PMID: 21850490

7

Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.

Yelkenli İH, Ulupinar E, Korkmaz OT, Şener E, Kuş G, Filiz Z, Tunçel N. Yelkenli İH, et al. Among authors: korkmaz ot. J Mol Neurosci. 2016 Jun;59(2):280-9. doi: 10.1007/s12031-016-0757-0. Epub 2016 Apr 26. J Mol Neurosci. 2016. PMID: 27115671

8

Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease.

Korkmaz OT, Tunçel N. Korkmaz OT, et al. Curr Pharm Des. 2018;24(39):4693-4701. doi: 10.2174/1381612825666190111150953. Curr Pharm Des. 2018. PMID: 30636594 Review.

9

The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats.

Tore F, Korkmaz OT, Dogrukol-Ak D, Tunçel N. Tore F, et al. Among authors: korkmaz ot. J Mol Neurosci. 2010 Jun;41(2):288-93. doi: 10.1007/s12031-009-9310-8. Epub 2009 Nov 20. J Mol Neurosci. 2010. PMID: 19936638

10

A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates.

Yeniceli D, Sener E, Korkmaz OT, Doğrukol-Ak D, Tuncel N. Yeniceli D, et al. Among authors: korkmaz ot. Talanta. 2011 Mar 15;84(1):19-26. doi: 10.1016/j.talanta.2010.11.063. Epub 2010 Dec 21. Talanta. 2011. PMID: 21315892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters